Devices and methods for adjusting basal delivery profile

Patent metadata

Field	Value
Publication number	US-9248231-B2
Application number	US-201013376040-A
Country	US
Kind code	B2
Filing date	Jun 3, 2010
Priority date	Jun 4, 2009
Publication date	Feb 2, 2016
Grant date	Feb 2, 2016

Abstract

The present disclosure presents systems, devices and methods for administration of a therapeutic fluid to the body of a patient at a transient basal delivery profile, and enabling modification of the transient profile. Some embodiments include a user interface enabling input of one or more transient basal related parameters, and a processor having a basal programming application operating thereon. The basal programming application configured for determining a transient basal profile based on at least one or more transient basal related parameters. The transient basal profile comprises a plurality of phases and wherein each of the plurality of phases is characterized by a duration and at least one basal rate. In some embodiments, at least one of the plurality of phases includes either a basal overshot or a basal undershot. Some embodiments may also include a pump for dispensing the therapeutic fluid from a reservoir to the body of the patient.

First claim

What is claimed is:

1. A method for adjusting a transient basal delivery profile for a therapeutic fluid delivered to the body of a patient, the method comprising:
providing a therapeutic fluid dispending device, the device including:
a user interface enabling input of one or more transient basal related parameters;
a processor having a basal programming application operating thereon; and
a pump dispensing the therapeutic fluid from a reservoir to the body of a patient;

receiving, via the user interface, the one or more transient basal related parameters;
determining, via the basal programming application, a transient basal profile based on at least the one or more transient basal related parameters, wherein the transient basal profile comprises two or more phases and wherein at least one of the two or more phases includes either a basal overshot or a basal undershot.

2. The method of claim 1 , further comprising controlling, via the basal programming application used in conjunction with the processor, the pump for dispensing the therapeutic fluid according to the transient basal profile.

3. The method of claim 1 , wherein determining the one or more transient basal related parameters includes:
determining a therapeutic fluid delivery rate substantially higher than the delivery rate in a steady state; and
receiving a therapeutic fluid delivery duration substantially shorter than the delivery duration in a steady state.

4. The method of claim 1 , wherein determining the transient basal profile based on at least the one or more transient basal related parameters includes:
determining a therapeutic fluid delivery rate substantially lower than the delivery rate in a steady state; and determining a therapeutic fluid delivery duration substantially shorter than the delivery duration in a steady state.

5. The method of claim 1 , wherein the therapeutic fluid total dose corresponding to the transient basal profile determined by the basal programming application is substantially equivalent to a total dose delivered in a steady state.

6. The method of claim 1 , wherein the one or more transient basal related parameters is selected from a group consisting of time of transient delivery rate, percentage of transient delivery rate compared to the anticipated delivery profile, percentage of transient delivery rate compared to the current delivery profile, absolute value or values of a delivery rate, maximum allowable time shifted bolus, minimum allowable time shifted negative bolus, an absorption rate of the therapeutic fluid, type of therapeutic fluid, intensity of physical activity, and site of cannula insertion.

7. The method of claim 1 , further comprising displaying the transient basal delivery profile to a user.

8. The method of claim 1 , wherein the transient basal delivery profile further comprises at least one additional basal profile to be delivered during at least one additional basal duration.

9. The method of claim 1 , further comprising administering the therapeutic fluid, and wherein such administration complies with pharmacokinetic and/or pharmacodynamic parameters of the therapeutic fluid.

10. The method of claim 1 , wherein each of the two or more phases is characterized by a duration and at least one basal rate.

11. A computer program comprising computer-executable instructions, which when executed on a suitable computer device, perform the method comprising:
receiving, via a user interface, one or more transient basal related parameters;
determining, via a basal programming application, a transient basal profile based on at least the one or more transient basal related parameters, wherein the transient basal profile comprises two or more phases and wherein at least one of the two or more phases includes either a basal overshot or a basal undershot.

12. The computer program of claim 11 , wherein the method further comprises controlling, via the basal programming application used in conjunction with the processor, the pump for dispensing the therapeutic fluid according to the transient basal profile.

13. The computer program of claim 11 , wherein determining the one or more transient basal related parameters includes:
determining a therapeutic fluid delivery rate substantially higher than the delivery rate in a steady state; and
receiving a therapeutic fluid delivery duration substantially shorter than the delivery duration in a steady state.

14. The computer program of claim 11 , wherein determining the transient basal profile based on at least the one or more transient basal related parameters includes:
determining a therapeutic fluid delivery rate substantially lower than the delivery rate in a steady state; and
determining a therapeutic fluid delivery duration substantially shorter than the delivery duration in a steady state.

15. The computer program of claim 11 , wherein the therapeutic fluid total dose corresponding to the transient basal profile determined by the basal programming application is substantially equivalent to a total dose delivered in a steady state.

16. The computer program of claim 11 , wherein the one or more transient basal related parameters is selected from a group consisting of: time of transient delivery rate, percentage of transient delivery rate compared to the anticipated delivery profile, percentage of transient delivery rate compared to the current delivery profile, absolute value or values of a delivery rate, maximum allowable time shifted bolus, minimum allowable time shifted negative bolus, an absorption rate of the therapeutic fluid, type of therapeutic fluid, intensity of physical activity, and site of cannula insertion.

17. The computer program of claim 11 , wherein the method further comprises displaying the transient basal delivery profile to a user.

18. The computer program of claim 11 , wherein the transient basal delivery profile further comprises at least one additional basal profile to be delivered during at least one additional basal duration.

19. The computer program of claim 11 , wherein the method further comprises administering the therapeutic fluid, and wherein such administration complies with pharmacokinetic and/or pharmacodynamic parameters of the therapeutic fluid.

20. A non-transitory computer readable medium comprising computer-executable instructions recorded thereon for performing the method comprising:
receiving, via a user interface, one or more transient basal related parameters;
determining, via a basal programming application, a transient basal profile based on at least the one or more transient basal related parameters, wherein the transient basal profile comprises two or more phases and wherein at least one of the two or more phases includes either a basal overshot or a basal undershot.

Assignees

• Yodfat Ofer
• Shapira Gali
• Roche Diabetes Care Inc

Inventors

• Yodfat Ofer
• Shapira Gali

Classifications

• A61M2230/005

  Parameter used as control input for the apparatus · CPC title

• A61M2205/3592

  using telemetric means, e.g. radio or optical transmission · CPC title

• A61M2005/14268

  with a reusable and a disposable component · CPC title

• A61M2005/14208

  with a programmable infusion control system, characterised by the infusion program · CPC title

• A61M5/14248 Primary

  of the skin patch type · CPC title